Moreover, stimulation of the PD-L1 receptor on cancer cells inhibits the programmed cell death (apoptosis) signal, thus inhibiting mediating cytotoxic CD8+ T lymphocyte (CTLs) anti-tumour cytotoxicity and the activation of death-inducing complex (DISC), as well as subsequent Fas-mediated target tumour killing. The gene discussed is FAS; the disease is cancer.